- About MMC
- Contract Process
- How to Use
- Application for Material Transfer
- Events
- Laws and Guidelines related to Material Transfer
- My Page
to get the detailed information about the material.| Material number |
Category | Name | Function | Intellectual property rights |
Price | Order or Joint Research Request |
|---|---|---|---|---|---|---|
| KYU QM2010-0028 |
Animal and Cell line from human (cell strain/cell line) |
anti KS-13 monoclonal antibody (hybridoma)
|
anti KS-13 antibody induces the differetiation of mouse leukemia cell and binds the human positive leukemia cell. | Patented/Patent Pending |
Academia: Cost of transaction Company: Negotiable |
|
| KYU QM2010-0027 |
Chemical Compound (undefined) |
KS-13
|
KS-13 inhibits differentiation of tissue-specific stem cell. | Patented/Patent Pending |
Academia: Cost of transaction Company: Negotiable |
|
| KYU QM2010-0016 |
Animal and Cell line from human (animal) |
Ogg1 knockout mouse (hetrozygote)
|
Ogg1 knockout mouse (hetrozygote) | None |
Academia: Cost of transaction Company: Negotiable |
|
| KYU QM2010-0008 |
Chemical Compound (organic compound) |
graphene thin film
|
It is expected to be used for device such as transistor, transparent electrode and LSI. | Patented/Patent Pending |
Academia: Cost of transaction Company: Negotiable |
|
| KYU QM2010-0002 |
Animal and Cell line from human (animal) |
Itpa knockout mouse (hetrozygote)
|
Inosine triphosphatase(Itpa) knockout mouse (hetrozygote) | None |
Academia: Cost of transaction Company: Negotiable |
|
| KYU QM2009-0057 |
Animal and Cell line from human (cell strain/cell line) |
AE6F4/CHO
|
Recombinant CHO cells producing AE6F4 | None |
Academia: Cost of transaction Company: Negotiable |
|
| KYU QM2009-0046 |
Antibody (undefined) |
anti-ginsenoside Rg1 monoclonal antibody
|
specific to ginsenoside Rg1 | Patented/Patent Pending |
Academia: Cost of transaction Company: Negotiable |
|
| KYU QM2009-0040 |
Gene / Protein (undefined) |
the integration vector p2Cmr and p3Kmr
|
donor plasmid for gene integlation using Cre recombinase | None |
Academia: Cost of transaction Company: Negotiable |
|
| KYU QM2009-0036 |
Animal and Cell line from human (cell strain/cell line) |
the Jurkat Cell line that is stably expressing hTNFalpha
|
the Jurket Cell line that is stably expressing human TNFalfa | Patented/Patent Pending |
Academia: Cost of transaction Company: Negotiable |
|
| KYU QM2009-0030 |
Antibody (undefined) |
anti RDX monolonal antibody (hybridoma)
|
anti trimethylene trinitramine (RDX) monolonal antibody (hybridoma) | None |
Academia: Cost of transaction Company: Negotiable |
|
| ｜＜ ＜ 31 32 33 34 35 36 37 38 39 40 ＞ ＞｜ | ||||||
Links